General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Guilemany JM et al. - Patients with PER have a moderate loss of smell (BAST-24) with a higher impairment in those with self-reported hyposmia and moderate-to-severe PER. These results suggest that the sense of smell should be further investigated in all patients with allergic rhinitis, both in a clinical setting and in clinical trials.

Related Articles

Time Interval and the Factors Associated with the Development of Asthma in Patients with Allergic Rhinitis
Lung, 10/09/09    Relevance Score: 69%

Nonallergic Rhinitis Symptoms More Severe Than Allergic Rhinitis
ScienceDaily, 10/06/09    Relevance Score: 69%

Allergic rhinitis, histamine, and otitis media
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 68%

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 68%

Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis
Clinical and Experimental Immunology, 10/05/09    Relevance Score: 68%

Today in Allergy...keeping you current

The ImmunoCAP Rapid Wheeze/Rhinitis Child test is useful in the initial allergy diagnosis of children with respiratory symptoms
Pediatric Allergy and Immunology, 12/18/09

Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09

Investigational drugs for allergic rhinitis
Expert Opinion on Investigational Drugs, 12/17/09

Today in Nose...keeping you current

Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence
Clinical Otolaryngology, 12/18/09

Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09

Investigational drugs for allergic rhinitis
Expert Opinion on Investigational Drugs, 12/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address